表紙:放射線量管理の世界市場:2021-2030年
市場調査レポート
商品コード
983121

放射線量管理の世界市場:2021-2030年

Global Radiation Dose Management Market: Analysis and Forecast, 2021-2030

出版日: | 発行: BIS Research Inc. | ページ情報: 英文 394 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.72円
放射線量管理の世界市場:2021-2030年
出版日: 2021年01月14日
発行: BIS Research Inc.
ページ情報: 英文 394 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の放射線量管理の市場規模は予測期間中10.96%のCAGRで推移し、2019年の2億3110万米ドルから、2030年には5億6730万米ドルの規模に成長すると予測されています。高齢者人口の増加、放射線機器の設置基盤とスキャン件数の増加、慢性疾患およ生活習慣病の有病率の増加、診断装置の規制要件の拡大、放射線被曝の懸念の増加、放射線量管理の認知度の向上、放射線量管理イニシアチブの拡大などの要因が同市場の成長を推進しています。

当レポートでは、世界の放射線量管理の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、関連法規制、特許動向、価格分析、市場規模の推移・予測、モダリティ・製品・展開区分・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

エグゼクティブサマリー

第1章 市場概要

第2章 製品の定義

第3章 調査範囲

第4章 調査範囲・調査手法

第5章 COVID-19:影響分析

第6章 市場シナリオ

  • 発展の推移
  • 放射線量管理の動向
  • 世界の放射線量管理シナリオ
  • 前提因子・制約
  • 主要調査結果・市場機会分析
  • 市場力学
    • 概要
    • 影響分析
    • 市場推進因子
    • 市場抑制因子
    • 市場機会

第7章 競合情勢

  • 主な展開・戦略
  • 市場シェア分析

第8章 価格分析

  • 検査ごとの手動線量データ記録コスト
  • 放射線量管理ソフトウェアの価格
  • サーバー料金

第9章 産業分析

  • 特許分析
  • 規制要件
  • 関連法規制
  • アライアンス
  • 協会・コンソーシアム

第10章 市場分析・予測:モダリティ別

  • CTスキャナー
  • X線・CR・DR
  • マンモグラフィシステム
  • インターベンショナル血管造影システム・AngioCT
  • 透視システム
  • PETスキャナー・SPECT
  • ハイブリッドイメージング

第11章 市場分析・予測:製品別

  • Radimetrics Enterprise Platform
  • DoseWatch・Dose Watch Explorer
  • teamplay Dose
  • NEXO [DOSE]
  • tqm/Dose・DoseMonitor
  • Radiation Dose Monitor
  • Imalogix Platform
  • Syncro-Dose・Aspire AWS
  • NovaDose
  • DoseWise Portal
  • SafeCT
  • MyXrayDose
  • DoseM
  • Dose Tracking System
  • DoseTrack

第12章 市場分析・予測:展開モード別

  • Webベース
  • オンプレミス
  • クラウドベース

第13章 市場分析・予測:エンドユーザー

  • 病院
  • 診断センター
  • その他

第14章 市場分析・予測:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • その他の地域

第15章 企業プロファイル

  • Agfa-Gevaert Group
  • Bayer AG
  • Bracco
  • Canon Inc.
  • Fujifilm Holdings Corporation
  • Guerbet Group
  • General Electric Company
  • Imalogix
  • Infinitt Healthcare Co., Ltd.
  • Koninklijke Philips N.V.
  • Medic Vision Imaging Solutions Ltd.
  • Medsquare
  • MyXrayDose Ltd.
  • Novarad Corporation
  • PACSHealth, LLC
  • Qaelum NV
  • Sectra AB
  • SST Group Inc.
  • Siemens Healthineers, Inc.
  • Virtual Phantom, Inc.
図表

List of Tables

  • Table 1: Impact Analysis of Market Drivers and Restraints
  • Table 2: Company Distribution Based on Mode of Deployment
  • Table 1.1: Effective Radiation Dose for Adults for Radiology Procedures
  • Table 5.1: Vaccines Approved for COVID-19
  • Table 5.2: Imaging Procedures in 2020 and 2019 by Patient Service Locations, New York
  • Table 5.3: Imaging Procedures in 2020 and 2019 by Imaging Modality Types, New York
  • Table 5.4: COVID-19 Vaccines Granted for Emergency Use in North America
  • Table 5.5: Healthcare Expenditure During FY2020 Across Various Regions in Europe
  • Table 5.6: COVID-19 Vaccines Granted for Emergency Use in Europe
  • Table 5.7: COVID-19 Vaccines Granted for Emergency Use in Asia-Pacific
  • Table 5.8: COVID-19 Vaccines Granted for Emergency Use in Rest-of-the-World
  • Table 6.1: Impact Analysis of Market Drivers and Restraints
  • Table 9.1: Global Radiation Dose Management System Patent Technology and Their Application
  • Table 9.2: List of Major Regulatory Bodies
  • Table 9.3: Some of the Bills and Acts for Radiation Dose Management
  • Table 9.4: Some of the Alliances for Radiation Dose Management
  • Table 9.5: Associations/Consortiums of the Global Radiation Dose Management Market
  • Table 10.1: Effective Radiation Dose from Diagnostic CT Procedure
  • Table 10.2: Effective Price Range of CT Scan in Different States in the U.S. for CT Scans
  • Table 10.3: Effective Radiation Dose from Diagnostic X-Ray-Single Exposure
  • Table 11.1: Competitive Benchmarking
  • Table 11.2: Competitive Benchmarking
  • Table 11.3: Competitive Benchmarking
  • Table 11.4: Competitive Benchmarking
  • Table 11.5: Competitive Benchmarking
  • Table 11.6: Competitive Benchmarking
  • Table 11.7: Competitive Benchmarking
  • Table 11.8: Competitive Benchmarking
  • Table 11.9: Competitive Benchmarking
  • Table 11.10: Competitive Benchmarking
  • Table 11.11: Competitive Benchmarking
  • Table 11.12: Competitive Benchmarking
  • Table 11.13: Competitive Benchmarking
  • Table 11.14: Competitive Benchmarking
  • Table 11.15: Competitive Benchmarking
  • Table 12.1: Competitive Benchmarking on the basis of Mode of Deployment
  • Table 14.1: Number of Cases of Cancer Latin America, 2020
  • Table 14.2: Number of Cases of Cancer in Brazil, 2020
  • Table 14.3: Number of Cases of Cancer in Mexico, 2020

List of Figures

  • Figure 1: Global Radiation Dose Management Market Value, 2019-2030
  • Figure 2: Radiation Dose Management Market, Pre-COVID-19 and Post-COVID-19 Scenario, $Million
  • Figure 3: Dominating Segments of Global Radiation Dose Management Market, 2020 and 2030
  • Figure 4: Global Radiation Dose Management Market (by Modality), Share Analysis, 2020-2030
  • Figure 5: Global Radiation Dose Management Market (by Mode of Deployment), Share Analysis, 2020 and 2030
  • Figure 6: Global Radiation Dose Management Market (by End Users), Share Analysis, 2020 and 2030
  • Figure 7: Global Radiation Dose Management Market (by Region), 2020
  • Figure 8: Key Strategies Incorporated by the Key Players in the Radiation Dose Management Market (January 2012-November 2020)
  • Figure 9: Market Share Analysis for the Global Radiation Dose Management Market (by Company), 2019
  • Figure 1.1: Sources of Radiation Exposure in the U.S.
  • Figure 1.2: Dose From Natural Background Radiation (mSv)
  • Figure 1.3: Different Types of Radiation Doses
  • Figure 3.1: Global Radiation Dose Management: Market Segmentation
  • Figure 4.1: Radiation Dose Management Market Research Methodology
  • Figure 4.2: Primary Research
  • Figure 4.3: Secondary Research
  • Figure 4.4: Considered Factors for Data Prediction and Modeling
  • Figure 4.5: Total Number of Companies Profiled
  • Figure 4.6: Assumptions and Limitations
  • Figure 5.1: Long-, Mid-, and Short-Term Impact of COVID-19 on Radiation Dose Management Market
  • Figure 5.2: Number of Scans by Imaging Modalities in the U.K. from January 2020- May 2020
  • Figure 5.3: Radiation Dose Management Market, Pre-COVID-19 and Post-COVID-19 Scenarios, $Million
  • Figure 5.4: Product Demand for Radiation Dose Management Software
  • Figure 5.5: Various Technological Opportunity Came During COVID-19
  • Figure 5.6: Recommendations for Hospitals to Optimize the Radiation Dose Process
  • Figure 6.1: Historic Evolution of X-Rays
  • Figure 6.2: Historical Evolution of Radiation Dose Management Software
  • Figure 6.3: Global Radiation Dose Management Market, 2019-2030
  • Figure 6.4: Market Dynamics
  • Figure 6.5: Number of Scans by Imaging Modalities in the U.K. From 2015-16 to 2019-20
  • Figure 6.6: Geriatric Population (60 Years and Above) Worldwide in Different Regions, 2000, 2015, 2030, and 2050
  • Figure 6.7: Number of Incidence Cases of Cancer in 2018 and 2040
  • Figure 6.8: Regulatory Bodies for Radiology Diagnostic Devices
  • Figure 6.9: Major Concerns Related to Overexposure of Radiation in Medical Imaging Devices and Procedures
  • Figure 7.1: Share of Key Developments and Strategies, January 2012-November 2020
  • Figure 7.2: Collaborations, Agreements, and Partnerships (by Company), January 2012-November 2020
  • Figure 7.3: Product Launches and Approvals (by Company), January 2012- November 2020
  • Figure 7.4: Regulatory Approvals (by Company), January 2012-November 2020
  • Figure 7.5: Mergers and Acquisitions (by Company), January 2012-November 2020
  • Figure 7.6: Market Share Analysis for the Global Radiation Dose Management Market (by Company), 2019
  • Figure 9.1: Patent Segmentation, by Year
  • Figure 9.2: Patent Segmentation, by Country
  • Figure 9.3: Patent Segmentation, by Modality
  • Figure 9.4: Patent Segmentation, by Modality Type
  • Figure 10.1: Segmentation of Radiation Dose Management Market, by Modality
  • Figure 10.2: Global Radiation Dose Management Market (by Modality), Market Share, 2020
  • Figure 10.3: Global Radiation Dose Management Market (by Modality), 2019-2030
  • Figure 10.4: Benefits of the CT scan
  • Figure 10.5: CT Scanner in the Global Radiation Dose Management Market, 2019-2030
  • Figure 10.6: CT Scanners Radiation Dose Management Market (by Region), 2019-2030
  • Figure 10.7: X-Ray, CR, and DR in the Global Radiation Dose Management Market, 2019-2030
  • Figure 10.8: X-Ray, CR, and DR Radiation Dose Management Market (by Region), 2019-2030
  • Figure 10.9: Mammography Systems in the Global Radiation Dose Management Market, 2019-2030
  • Figure 10.10: Mammography Systems Radiation Dose Management Market (by Region), 2019-2030
  • Figure 10.11: Interventional Angiography Systems/Angio CT in the Global Radiation Dose Management Market, 2019-2030
  • Figure 10.12: Interventional Angiography Systems/Angio CT Radiation Dose Management Market (by Region), 2019-2030
  • Figure 10.13: Benefits of Fluoroscopy System
  • Figure 10.14: Fluoroscopy Systems in the Global Radiation Dose Management Market, 2019-2030
  • Figure 10.15: Fluoroscopy Systems Radiation Dose Management Market (by Region), 2019-2030
  • Figure 10.16: PET Scanners and SPECT in the Global Radiation Dose Management Market, 2019-2030
  • Figure 10.17: PET Scanners and SPECT Radiation Dose Management Market (by Region), 2019-2030
  • Figure 10.18: Hybrid Imaging in the Global Radiation Dose Management Market, 2019-2030
  • Figure 10.19: Hybrid Imaging Radiation Dose Management Market (by Region), 2019-2030
  • Figure 11.1: Segmentation of Radiation Dose Management Market, (by Product Type)
  • Figure 11.2: Global Radiation Dose Management Market (by Product Type), 2020 and 2030
  • Figure 11.3: Global Radiation Dose Management Market (Radimetrics Enterprise Platform), 2019-2030
  • Figure 11.4: Installed Base and Number of Customers, 2018 and 2019
  • Figure 11.5: Compatible Modalities of Radimetrics Enterprise Platform
  • Figure 11.6: Global Radiation Dose Management Market (DoseWatch), 2019-2030
  • Figure 11.7: Installed Base and Number of Customers, 2018 and 2019
  • Figure 11.8: Compatible Modalities of DoseWatch
  • Figure 11.9: Global Radiation Dose Management Market (teamplay Dose), 2019-2030
  • Figure 11.10: Installed Base and Number of Customers, 2018 and 2019
  • Figure 11.11: Compatible Modalities of teamplay Dose
  • Figure 11.12: Global Radiation Dose Management Market (NEXO [DOSE]), 2019-2030
  • Figure 11.13: Installed Base and Number of Customers, 2018 and 2019
  • Figure 11.14: Compatible Modalities of NEXO [DOSE]
  • Figure 11.15: Global Radiation Dose Management Market ( tqm/Dose and DoseMonitor), 2019-2030
  • Figure 11.16: Installed Base and Number of Customers, 2019 and 2020
  • Figure 11.17: Compatible Modalities of tqm/Dose and DoseMonitor
  • Figure 11.18: Global Radiation Dose Management Market (Radiation Dose Monitor), 2019-2030
  • Figure 11.19: Installed Base and Number of Customers, 2018 and 2019
  • Figure 11.20: Compatible Modalities of Radiation Dose Monitor
  • Figure 11.21: Global Radiation Dose Management Market (Imalogix Platform), 2019-2030
  • Figure 11.22: Installed Base and Number of Customers, 2018 and 2019
  • Figure 11.23: Compatible Modalities of Imalogix Platform
  • Figure 11.24: Global Radiation Dose Management Market (Syncro-Dose), 2019-2030
  • Figure 11.25: Installed Base and Number of Customers, 2018 and 2019
  • Figure 11.26: Compatible Modalities of Syncro-Dose
  • Figure 11.27: Global Radiation Dose Management Market (NovaDose), 2019-2030
  • Figure 11.28: Installed Base and Number of Customers, 2018 and 2019
  • Figure 11.29: Compatible Modalities of NovaDose
  • Figure 11.30: Global Radiation Dose Management Market (DoseWise Portal), 2019-2030
  • Figure 11.31: Installed Base and Number of Customers, 2018 and 2019
  • Figure 11.32: Compatible Modalities of DoseWise Portal
  • Figure 11.33: Global Radiation Dose Management Market (SafeCT), 2019-2030
  • Figure 11.34: Installed Base and Number of Customers, 2018 and 2019
  • Figure 11.35: Compatible Modalities of SafeCT
  • Figure 11.36: Global Radiation Dose Management Market (MyXrayDose), 2019-203
  • Figure 11.37: Installed Base and Number of Customers, 2018 and 2019
  • Figure 11.38: Compatible Modalities of MyXrayDose
  • Figure 11.39: Global Radiation Dose Management Market (DoseM), 2019-2030
  • Figure 11.40: Installed Base and Number of Customers, 2018 and 2019
  • Figure 11.41: Compatible Modalities of DoseM
  • Figure 11.42: Global Radiation Dose Management Market (Dose Tracking System), 2019-2030
  • Figure 11.43: Installed Base and Number of Customers, 2018 and 2019
  • Figure 11.44: Compatible Modalities of the Dose Tracking System
  • Figure 11.45: Global Radiation Dose Management Market (DoseTrack), 2019-2030
  • Figure 11.46: Installed Base and Number of Customers, 2018 and 2019
  • Figure 11.47: Compatible Modalities of DoseTrack
  • Figure 12.1: Segmentation of Radiation Dose Management Market (by Mode of Deployment)
  • Figure 12.2: Global Radiation Dose Management Market (by Mode of Deployment), 2019-2030
  • Figure 12.3: Global Radiation Dose Management Installed Base (by Mode of Deployment), 2019-2030
  • Figure 12.4: Global Radiation Dose Management Market (Web-Based), 2019-2030
  • Figure 12.5: Web-Based Radiation Dose Management Market (by Region), 2019-2030
  • Figure 12.6: Global Radiation Dose Management Market (On-Premises), 2019-2030
  • Figure 12.7: On-Premises Radiation Dose Management Market (by Region), 2019-2030
  • Figure 12.8: Global Radiation Dose Management Market (Cloud-Based), 2019-2030
  • Figure 12.9: Cloud-Based Radiation Dose Management Market (by Region), 2019-2030
  • Figure 13.1: Segmentation of Radiation Dose Management Market (by End User)
  • Figure 13.2: Global Radiation Dose Management Market (by End User), 2020 and 2030
  • Figure 13.3: Global Radiation Dose Management Market (Hospital), 2019-2030
  • Figure 13.4: Global Radiation Dose Management Market (Diagnostic Centers), 2019-2030
  • Figure 13.5: Global Radiation Dose Management Market (by Others), 2019-2030
  • Figure 14.1: Global Radiation Dose Management Market (by Region), 2020
  • Figure 14.2: Global Radiation Dose Management Market (by Region), $Million, 2019-2030
  • Figure 14.3: North America Radiation Dose Management Market, $Million, 2019-2030
  • Figure 14.4: North America: Market Dynamics
  • Figure 14.5: North America: Radiation Dose Management Market (by Modality), 2019-2030
  • Figure 14.6: North America: Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.7: North America: Radiation Dose Management Market (by Country), 2020 and 2030
  • Figure 14.8: Patient Data of New Cancer Cases by Cancer Type in the U.S.(2020)
  • Figure 14.9: U.S. Radiation Dose Management Market, 2019-2030
  • Figure 14.10: U.S. Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.11: Number of Units of Imaging Devices in Canada in 2017
  • Figure 14.12: Key Features of Imaging Devices in Canada
  • Figure 14.13: Canada Radiation Dose Management Market, 2019-2030
  • Figure 14.14: Canada Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.15: Europe Radiation Dose Management Market, 2019-2030
  • Figure 14.16: Europe Market Dynamics
  • Figure 14.17: Europe Radiation Dose Management Market (by Modality), 2019-2030
  • Figure 14.18: Europe Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.19: Europe Radiation Dose Management Market (by Country), 2019-2030
  • Figure 14.20: Germany Radiation Dose Management Market, 2019-2030
  • Figure 14.21: Germany Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.22: France Radiation Dose Management Market, 2019-2030
  • Figure 14.23: France Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.24: Italy Radiation Dose Management Market, 2019-2030
  • Figure 14.25: Italy Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.26: U.K. Radiation Dose Management Market, 2019-2030
  • Figure 14.27: U.K. Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.28: Spain Radiation Dose Management Market, 2019-2030
  • Figure 14.29: Spain Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.30: Netherlands Radiation Dose Management Market, 2019-2030
  • Figure 14.31: Netherlands Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.32: Russia Radiation Dose Management Market, 2019-2030
  • Figure 14.33: Russia Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.34: Rest-of-Europe Radiation Dose Management Market, 2019-2030
  • Figure 14.35: Rest-of-Europe Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.36: Asia-Pacific Radiation Dose Management Market, $Million, 2019-2030
  • Figure 14.37: Asia-Pacific Market Dynamics
  • Figure 14.38: Asia-Pacific Radiation Dose Management Market (by Modality), 2019-2030
  • Figure 14.39: Asia-Pacific Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.40: Asia-Pacific Radiation Dose Management Market (by Country), 2019-2030
  • Figure 14.41: Recommendations by the Science Council of Japan (2017)
  • Figure 14.42: Japan Radiation Dose Management Market, 2019-2030
  • Figure 14.43: Japan Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.44: China Radiation Dose Management Market, 2019-2030
  • Figure 14.45: China Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.46: Australia and New Zealand Radiation Dose Management Market, 2019-2030
  • Figure 14.47: Australia and New Zealand Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.48: South Korea Radiation Dose Management Market, 2019-2030
  • Figure 14.49: South Korea Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.50: India Radiation Dose Management Market, 2019-2030
  • Figure 14.51: India Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.52: Rest-of-Asia-Pacific Radiation Dose Management Market, 2019-2030
  • Figure 14.53: Rest of Asia-Pacific Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.54: Latin America Radiation Dose Management Market, 2019-2030
  • Figure 14.55: Latin America Market Dynamics
  • Figure 14.56: Latin America Radiation Dose Management Market (by Modality), 2019-2030
  • Figure 14.57: Latin America Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.58: Latin America Radiation Dose Management Market (by Country), 2019-2030
  • Figure 14.59: Brazil Radiation Dose Management Market, 2021-2030
  • Figure 14.60: Brazil Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.61: Mexico Radiation Dose Management Market, 2019-2030
  • Figure 14.62: Mexico Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.63: Rest-of-Latin America Radiation Dose Management Market, 2019-2030
  • Figure 14.64: Rest-of-Latin America Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.65: Rest-of-the-World Radiation Dose Management Market, 2019-2030
  • Figure 14.66: Middle East and Africa Market Dynamics
  • Figure 14.67: Rest-of-the-World Radiation Dose Management Market (by Modality), 2019-2030
  • Figure 14.68: Rest-of-the-World Radiation Dose Management Market (by End User), 2021-2030
  • Figure 14.69: Rest-of-the-World Radiation Dose Management Market (by Country), 2019-2030
  • Figure 14.70: Middle East Radiation Dose Management Market, 2019-2030
  • Figure 14.71: Middle East Radiation Dose Management Market (by End User), 2019-2030
  • Figure 14.72: Africa Radiation Dose Management Market, 2019-2030
  • Figure 14.73: Africa Radiation Dose Management Market (by End User), 2019-2030
  • Figure 15.1: Agfa Gevaert Group - Product Portfolio for Radiation Dose Management Solutions Market
  • Figure 15.2: Agfa Gevaert Group - Overall Financials, 2017-2019
  • Figure 15.3: Agfa-Gevaert Group- Revenue (by Segment), 2017-2019
  • Figure 15.4: Agfa Gevaert Group - Revenue (by Region), 2017-2019
  • Figure 15.5: Agfa Gevaert Group - R&D Expenditure, 2017-2019
  • Figure 15.6: SWOT Analysis - Agfa Gevaert Group
  • Figure 15.7: Bayer AG- Product Portfolio for Radiation Dose Management Market
  • Figure 15.8: Bayer AG - Overall Financials, 2017-2019
  • Figure 15.9: Bayer AG - Revenue (by Segment), 2017-2019
  • Figure 15.10: Bayer AG - Revenue (by Region), 2017-2019
  • Figure 15.11: Bayer AG- R&D Expenditure, 2017-2019
  • Figure 15.12: SWOT Analysis - Bayer AG
  • Figure 15.13: Bracco - Product Portfolio for Radiation Dose Management Market
  • Figure 15.14: SWOT Analysis - Bracco
  • Figure 15.15: Canon Inc. - Product Portfolio for Radiation Dose Management Market
  • Figure 15.16: Canon Inc. - Overall Financials, 2017-2019
  • Figure 15.17: Canon Inc. - Revenue (by Segment), 2017-2019
  • Figure 15.18: Canon Inc. - Revenue (by Region), 2017-2019
  • Figure 15.19: Canon Inc. - R&D Expenditure, 2017-2019
  • Figure 15.20: SWOT Analysis - Canon Inc.
  • Figure 15.21: Fujifilm Holdings Corporation - Product Radiation Dose Management Market
  • Figure 15.22: Fujifilm Holdings Corporation - Overall Financials, 2017-2019
  • Figure 15.23: Fujifilm Holdings Corporation - Revenue (by Segment), 2017-2019
  • Figure 15.24: Fujifilm Holdings Corporation - Revenue (by Region), 2017-2019
  • Figure 15.25: Fujifilm Holdings Corporation - R&D Expenditure, 2017-2019
  • Figure 15.26: SWOT Analysis - Fujifilm Holdings Corporation
  • Figure 15.27: Guerbet Group- Product Portfolio for Radiation Dose Management Market
  • Figure 15.28: Guerbet Group. - Overall Financials, 2017-2019
  • Figure 15.29: Guerbet Group - Revenue (by Segment), 2017-2019
  • Figure 15.30: Guerbet Group - Revenue (by Region), 2017-2019
  • Figure 15.31: SWOT Analysis - Guerbet LLC
  • Figure 15.32: General Electric Company - Product Portfolio for Radiation Dose Management Market
  • Figure 15.33: General Electric Company - Overall Financials, 2017-2019
  • Figure 15.34: General Electric Company - Revenue (by Segment), 2017-2019
  • Figure 15.35: General Electric Company (GE Healthcare) - Revenue (by Region), 2017-2019
  • Figure 15.36: General Electric Company - R&D Expenditure, 2017-2019
  • Figure 15.37: SWOT Analysis - General Electric Company
  • Figure 15.38: Imalogix - Product Portfolio for Radiation Dose Management Market
  • Figure 15.39: SWOT Analysis - Imalogix
  • Figure 15.40: Infinitt Healthcare Co. Ltd- Product Portfolio for Radiation Dose Management Market
  • Figure 15.41: SWOT Analysis - Infinitt Healthcare Co., Ltd.
  • Figure 15.42: Koninklijke Philips N.V. - Product Portfolio for Radiation Dose Management Market
  • Figure 15.43: Koninklijke Philips N.V. - Overall Financials, 2017-2019
  • Figure 15.44: Koninklijke Philips N.V. - Revenue (by Segment), 2017-2019
  • Figure 15.45: Koninklijke Philips N.V. - Revenue (by Region), 2017-2019
  • Figure 15.46: Koninklijke Philips N.V. - R&D Expenditure, 2017-2019
  • Figure 15.47: SWOT Analysis - Koninklijke Philips N.V.
  • Figure 15.48: Medic Vision Imaging Solutions Ltd. - Product Portfolio
  • Figure 15.49: SWOT Analysis - Medic Vision Imaging Solutions Ltd.
  • Figure 15.50: Medsquare - Product Portfolio for Radiation Dose Management Market
  • Figure 15.51: SWOT Analysis - Medsquare
  • Figure 15.52: MyXrayDose, Ltd. - Product Portfolio
  • Figure 15.53: SWOT Analysis - MyXrayDose, Ltd.
  • Figure 15.54: Novarad Corporation - Product Portfolio
  • Figure 15.55: SWOT Analysis - Novarad Corporation
  • Figure 15.56: PACSHealth, LLC - Product Portfolio for Radiation Dose Management Market
  • Figure 15.57: SWOT Analysis - PACSHealth, LLC
  • Figure 15.58: Qaelum NV - Product Portfolio for Radiation Dose Management Market
  • Figure 15.59: SWOT Analysis - Qaelum NV
  • Figure 15.60: Sectra AB - Product Portfolio for Radiation Dose Management
  • Figure 15.61: Sectra AB - Overall Financials, 2017/18-2019/20
  • Figure 15.62: Sectra AB - Revenue (by Segment), 2017/8-2019/20
  • Figure 15.63: Sectra AB - Revenue (by Region), 2017/18-2019/20
  • Figure 15.64: Sectra AB - R&D Expenditure, 2017/18-2019/20
  • Figure 15.65: SWOT Analysis - Sectra AB
  • Figure 15.66: SST Group, Inc. - Product Portfolio for Radiation Dose Management Market
  • Figure 15.67: SWOT Analysis - SST Group Inc.
  • Figure 15.68: Siemens Healthineers, Inc. - Product Portfolio for Radiation Dose Management Market
  • Figure 15.69: Siemens Healthineers, Inc. - Overall Financials, 2018-2020
  • Figure 15.70: Siemens Healthineers, Inc. - Revenue (by Segment), 2018-2020
  • Figure 15.71: Siemens Healthineers, Inc. - Revenue (by Region), 2018-2020
  • Figure 15.72: Siemens Healthineers, Inc. - R&D Expenditure, 2018-2020
  • Figure 15.73: SWOT Analysis - Siemens Healthineers, Inc.
  • Figure 15.74: Virtual Phantom, Inc.- Product Portfolio for Radiation Dose Management Market
  • Figure 15.75: SWOT Analysis - Virtual Phantoms Inc.
目次
Product Code: BHD0692SC

"Radiation Dose Management Market to Reach $567.3 Million by 2030."

Market Report Coverage - Radiation Dose Management

Market Segmentation

  • Modality-CT Scanners, X-Ray, CR and DR, Mammography System, Interventional Angiography Systems/Angio CT, Fluoroscopy systems, PET scanners and SPECT, and Hybrid Imaging.
  • Mode of Deployment- Web-Based, On-Premises, and Cloud-Based
  • Products- Radimetrics Enterprise Platform, DoseWatch, Teamplay Dose, Nexo [Dose], tqm/Dose and DoseMonitor, Radiation Dose Monitor, Imalogix Platform, Syncro-Dose, NovaDose, DoseWIse Portal, SafeCT, MYXrayDose, DoseM, Dose Tracking System and DoseTrack
  • End-User- Hospital, Diagnostic Centers and others

Regional Segmentation

  • North America - U.S., Canada
  • Europe - Germany, U.K., France, Italy, Spain, Netherlands, Russia and Rest-of-Europe
  • Asia-Pacific - Japan, China, India, South Korea, Australia and New Zealand, and Rest-of-Asia-Pacific
  • Latin America-Brazil, Mexico, and Rest-of-Latin America
  • Rest-of-the-World - Middle East, and Africa

Growth Drivers

  • Growing geriatric population
  • Increasing installed bases of radiology equipment and number of scans
  • Increasing prevalence of chronic and lifestyle associated diseases
  • Increasing regulatory requirements for diagnostic devices
  • Increasing concern related to radiation exposure
  • Growing awareness and initiatives for radiation dose management

Market Challenges

  • Lack of skilled and trained professionals
  • Lack of benchmarking of dose optimization
  • High cost associated with radiation dose management system

Market Opportunities

  • Technological advancements in medical imaging
  • Impact of cloud-based solutions
  • Regulatory focus on pediatric procedures
  • Regional expansion and increasing adoption of radiation dose management software in emerging economies

Key Companies Profiled

Agfa-Gevaert Group, Bayer AG, Bracco, Canon Inc., Fujifilm Holdings Corporation, Guerbet Group, General Electric Company, Imalogix, Infinitt Healthcare Co., ltd., Koninklijke Philips N.V., Medic Vision Imaging Solutions Ltd., Medsquare, MyXrayDose Ltd., Novarad Coroporation, PACSHealth, LLC, Qaelum NV, Sectra AB, SST Group Inc., Siemens Healthineers, Inc., and Virtual Phantom, Inc.

Key Questions Answered in this Report:

  • How has COVID-19 impacted the global radiation dose management market?
  • What are the key regulations for the development, commercialization, and adoption of radiation dose management?
  • How does the pricing of the radiation dose software impact the overall market growth?
  • Which are the leading players that currently hold significant dominance in the global radiation dose management market?
  • What are the key strategies incorporated by the players of the global radiation dose management market to sustain the competition and retain their supremacy?
  • What is the patent landscape of the radiation dose management market for different modalities?
  • What is the current annual demand for different radiation dose management modalities, end user, and mode of deployment across different regions? What is their growth potential over the forecast period (2021-2030)?
  • What is the current market potential of radiation dose management, and what are the factors deciding the growth potential of radiation dose management for the forecast period?
  • What is the current revenue contribution of different modalities, and how would it evolve in the forecast period?
  • What are the various types of radiation dose management products available in the market? How many units of products have been installed in 2017, 2018, and 2019, respectively?
  • Which mode of deployment contributes to the highest CAGR (%) in the global radiation dose management market?
  • How does the end-user perception impact the growth of the global radiation dose management market?
  • Which countries contribute to a major share of the current demand, and which countries hold significant scope for expansion for business activities by players of the global radiation dose management market?

Market Overview

The radiation dose management market is witnessing a significant increase in the market size due to the ongoing COVID-19 pandemic. The overall market was estimated to be $231.1 million in FY2019, and it is expected to grow at a CAGR of 10.96% during the forecast period, 2021-2030. Presently, more than 21 companies are operating in this market, including already existing and emerging medical device companies.

Healthcare experts at BIS are continuously analyzing the impact of industrial and regulatory decisions on the radiation dose management market. The market is driven by certain factors such as growing geriatric population, increasing installed bases of radiology equipment and number of scans, increasing prevalence of chronic and lifestyle associated diseases, increasing regulatory requirements for diagnostic devices, increasing concern related to radiation exposure, and growing awareness and initiatives for radiation dose management.

Within the research report, the market is segmented based on product type, patient age, end-user, and regional analysis. Each of these segments covers the market's snapshot over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Table of Contents

Executive Summary

1 Market Overview

  • 1.1 Introduction
    • 1.1.1 Natural Radiation Sources
    • 1.1.2 Biological Effects of Radiation
    • 1.1.3 Usage of Radiation in Medical Devices
    • 1.1.4 Radiation Dose
    • 1.1.5 Effective Radiation Dose
    • 1.1.6 Factors Contributing to Unnecessary Radiation Exposure

2 Product Definition

3 Scope of Research Study

  • 3.1 Scope of the Study
  • 3.2 Exclusion Criteria of the Report
  • 3.3 Key Questions Answered in the Report
  • 3.4 Forecast Period Selection Criteria

4 Research Scope and Methodology

  • 4.1 Research Methodology
  • 4.2 Primary Data Sources
  • 4.3 Secondary Data Sources
  • 4.4 Data and Prediction Modeling
  • 4.5 Selection Criteria for Company Profiles
  • 4.6 Brief Overview of Market Estimation Process
  • 4.7 Data Validation
  • 4.8 Assumptions and Limitations

5 COVID-19 Impact Analysis

  • 5.1 Impact on Radiation Diagnostic Industry
    • 5.1.1 Industry Analysis
    • 5.1.2 Long-, Mid-, and Short-Term Impact
    • 5.1.3 Impact on Radiation Diagnostic Equipment (CT Scanners, X-Ray, Mammography System, PET Scanners and SPECT, and Others)
  • 5.2 Trend Analysis for Radiation Dose Management Market
    • 5.2.1 Pre-COVID-19
    • 5.2.2 Post-COVID-19
  • 5.3 Regional Impact of COVID-19 Industry
    • 5.3.1 North America
    • 5.3.2 Europe
    • 5.3.3 Asia-Pacific
    • 5.3.4 Rest-of-the-World
  • 5.4 Change in Competitive Landscape and Product Demand
  • 5.5 Emerging Opportunities due to COVID-19 in Radiation Dose Management
  • 5.6 Future Prospective: Post COVID-19 Scenarios and Recommendations

6 Global Radiation Dose Management Market Scenario

  • 6.1 Historical Trends
  • 6.2 Trends for Radiation Dose Management
  • 6.3 Global Radiation Dose Management Scenario
  • 6.4 Assumptions and Limitations
  • 6.5 Key Findings and Opportunity Assessment
    • 6.5.1 Key Findings
    • 6.5.2 Opportunity Assessment
  • 6.6 Market Dynamics
    • 6.6.1 Overview
    • 6.6.2 Impact Analysis
    • 6.6.3 Market Drivers
      • 6.6.3.1 Increasing Installed Bases of Radiology Equipment and Number of Scans
      • 6.6.3.2 Growing Geriatric Population
      • 6.6.3.3 Increasing Prevalence of Chronic and Lifestyle-Associated Diseases
        • 6.6.3.3.1 Increasing Prevalence of Cancer
        • 6.6.3.3.2 Increasing Prevalence of Cardiovascular Diseases
        • 6.6.3.3.3 Increasing Prevalence of Respiratory Diseases
      • 6.6.3.4 Increasing Regulatory Requirements for Diagnostic Devices
      • 6.6.3.5 Increasing Concern Related to Radiation Over Exposure
      • 6.6.3.6 Growing Awareness and Initiatives for Radiation Dose Management
    • 6.6.4 Market Restraints
      • 6.6.4.1 Lack of Skilled and Trained Professionals
      • 6.6.4.2 High Cost Associated with Radiation Dose Software
    • 6.6.5 Opportunities
      • 6.6.5.1 Innovation
        • 6.6.5.1.1 Technological Advancements in Medical Imaging
        • 6.6.5.1.2 Impact of Cloud-Based Solutions
      • 6.6.5.2 Regulatory Focus on Pediatric Procedures
        • 6.6.5.2.1 Radiation Dose Management for Pediatric Procedures
      • 6.6.5.3 Regional Expansion and Increasing Adoption of Radiation Dose Management Software in Emerging Economies

7 Competitive Landscape

  • 7.1 Key Developments and Strategies
    • 7.1.1 Collaborations, Agreements, and Partnerships
    • 7.1.2 Product Launches
    • 7.1.3 Regulatory Approvals
    • 7.1.4 Mergers and Acquisitions
  • 7.2 Market Share Analysis
    • 7.2.1 Market Share Analysis, by Company

8 Radiation Dose Management Pricing Analysis

  • 8.1 Manual Dose Data Recording Cost Per Examination
  • 8.2 Radiation Dose Management Software Pricing
  • 8.3 Server Fee

9 Industry Insights

  • 9.1 Patent Analysis
    • 9.1.1 Patent Analysis (by Modality Type)
  • 9.2 Regulatory Requirements
  • 9.3 Bills and Acts for Radiation Dose Management
  • 9.4 Alliances
  • 9.5 Associations and Consortiums

10 Global Radiation Dose Management Market (by Modality)

  • 10.1 CT Scanners
  • 10.2 X-Ray, CR, and DR
  • 10.3 Mammography System
  • 10.4 Interventional Angiography Systems/Angio CT
  • 10.5 Fluoroscopy Systems
  • 10.6 PET Scanners and SPECT
  • 10.7 Hybrid Imaging

11 Global Radiation Dose Management Market (by Product)

  • 11.1 Introduction
  • 11.2 Radimetrics Enterprise Platform
    • 11.2.1 Key Features
    • 11.2.2 Radimetrics Enterprise Platform- Global Market
    • 11.2.3 Installed Base and Number of Customers
    • 11.2.4 Compatible Modalities
    • 11.2.5 Competitive Benchmarking
  • 11.3 DoseWatch and Dose Watch Explorer
    • 11.3.1 Key Features
    • 11.3.2 DoseWatch and DoseWatch Explorer- Global Market
    • 11.3.3 Installed Base and Number of Customers
    • 11.3.4 Compatible Modalities
    • 11.3.5 Competitive Benchmarking
  • 11.4 teamplay Dose
    • 11.4.1 Key Features
    • 11.4.2 teamplay Dose- Global Market
    • 11.4.3 Installed Base and Number of Customers
    • 11.4.4 Compatible Modalities
    • 11.4.5 Competitive Benchmarking
  • 11.5 NEXO [DOSE]
    • 11.5.1 Key Features
    • 11.5.2 NEXO [DOSE]- Global Market
    • 11.5.3 Installed Base and Number of Customers
    • 11.5.4 Compatible Modalities
    • 11.5.5 Competitive Benchmarking
  • 11.6 tqm/Dose and DoseMonitor
    • 11.6.1 Key Features
    • 11.6.2 tqm/Dose and DoseMonitor- Global Market
    • 11.6.3 Installed Base and Number of Customers
    • 11.6.4 Compatible Modalities
    • 11.6.5 Competitive Benchmarking
  • 11.7 Radiation Dose Monitor
    • 11.7.1 Key Features
    • 11.7.2 Radiation Dose Monitor- Global Market
    • 11.7.3 Installed Base and Number of Customers
    • 11.7.4 Compatible Modalities
    • 11.7.5 Competitive Benchmarking
  • 11.8 Imalogix Platform
    • 11.8.1 Key Features
    • 11.8.2 Imalogix Platform- Global Market
    • 11.8.3 Installed Base and Number of Customers
    • 11.8.4 Compatible Modalities
    • 11.8.5 Competitive Benchmarking
  • 11.9 Syncro-Dose and Aspire AWS
    • 11.9.1 Key Features
    • 11.9.2 Syncro-Dose- Global Market
    • 11.9.3 Installed Base and Number of Customers
    • 11.9.4 Compatible Modalities
    • 11.9.5 Competitive Benchmarking
  • 11.1 NovaDose
    • 11.10.1 Key Features
    • 11.10.2 NovaDose- Global Market
    • 11.10.3 Installed Base and Number of Customers
    • 11.10.4 Compatible Modalities
    • 11.10.5 Competitive Benchmarking
  • 11.11 DoseWise Portal
    • 11.11.1 Key Features
    • 11.11.2 DoseWise Portal- Global Market
    • 11.11.3 Installed Base and Number of Customers
    • 11.11.4 Compatible Modalities
    • 11.11.5 Competitive Benchmarking
  • 11.12 SafeCT
    • 11.12.1 Key Features
    • 11.12.2 SafeCT- Global Market
    • 11.12.3 Installed Base and Number of Customers
    • 11.12.4 Compatible Modalities
    • 11.12.5 Competitive Benchmarking
  • 11.13 MyXrayDose
    • 11.13.1 Key Features
    • 11.13.2 MyXrayDose- Global Market
    • 11.13.3 Installed Base and Number of Customers
    • 11.13.4 Compatible Modalities
    • 11.13.5 Competitive Benchmarking
  • 11.14 DoseM
    • 11.14.1 Key Features
    • 11.14.2 DoseM- Global Market
    • 11.14.3 Installed Base and Number of Customers
    • 11.14.4 Compatible Modalities
    • 11.14.5 Competitive Benchmarking
  • 11.15 Dose Tracking System
    • 11.15.1 Key Features
    • 11.15.2 Dose Tracking System- Global Market
    • 11.15.3 Installed Base and Number of Customers
    • 11.15.4 Compatible Modalities
    • 11.15.5 Competitive Benchmarking
  • 11.16 DoseTrack
    • 11.16.1 Key Features
    • 11.16.2 DoseTrack- Global Market
    • 11.16.3 Installed Base and Number of Customers
    • 11.16.4 Compatible Modalities
    • 11.16.5 Competitive Benchmarking

12 Global Radiation Dose Management Market (by Mode of Deployment)

  • 12.1 Introduction
  • 12.2 Competitive Benchmarking
  • 12.3 Web-Based
  • 12.4 On-Premises
  • 12.5 Cloud-Based

13 Global Radiation Dose Management Market (by End Users)

  • 13.1 Introduction
  • 13.2 Hospital
  • 13.3 Diagnostic Centers
  • 13.4 Others

14 Global Radiation Dose Management Market (by Region)

  • 14.1 North America Radiation Dose Management Market
    • 14.1.1 North America: Radiation Dose Management Market (by Modality)
    • 14.1.2 North America: Radiation Dose Management (by End User)
    • 14.1.3 North America Radiation Dose Management Market (by Country)
      • 14.1.3.1 U.S.
        • 14.1.3.1.1 U.S. Radiation Dose Management (by End User)
      • 14.1.3.2 Canada
        • 14.1.3.2.1 Canada Radiation Dose Management (by End User)
    • 14.1.4 Regulation
    • 14.1.5 Developments
  • 14.2 Europe
    • 14.2.1 Europe Radiation Dose Management Market (by Modality)
    • 14.2.2 Europe Radiation Dose Management (by End User)
    • 14.2.3 Europe Radiation Dose Management Market (by Country)
      • 14.2.3.1 Germany
        • 14.2.3.1.1 Germany Radiation Dose Management (by End User)
      • 14.2.3.2 France
        • 14.2.3.2.1 France Radiation Dose Management (by End User)
      • 14.2.3.3 Italy
        • 14.2.3.3.1 Italy Radiation Dose Management (by End User)
      • 14.2.3.4 U.K.
        • 14.2.3.4.1 U.K. Radiation Dose Management (by End User)
      • 14.2.3.5 Spain
        • 14.2.3.5.1 Spain Radiation Dose Management (by End User)
      • 14.2.3.6 Netherlands
        • 14.2.3.6.1 Netherlands Radiation Dose Management (by End User)
      • 14.2.3.7 Russia
        • 14.2.3.7.1 Russia Radiation Dose Management (by End User)
      • 14.2.3.8 Rest-of-Europe
      • 14.2.3.9 Rest-of-Europe Radiation Dose Management (by End User)
    • 14.2.4 Regulation
    • 14.2.5 Developments
  • 14.3 Asia-Pacific Radiation Dose Management Market
    • 14.3.1 Asia-Pacific Radiation Dose Management Market (by Modality)
    • 14.3.2 Asia-Pacific Radiation Dose Management (by End User)
    • 14.3.3 Asia-Pacific Radiation Dose Management Market (by Country)
      • 14.3.3.1 Japan
        • 14.3.3.1.1 Japan Radiation Dose Management (by End User)
      • 14.3.3.2 China
        • 14.3.3.2.1 China Radiation Dose Management (by End User)
      • 14.3.3.3 Australia and New Zealand
        • 14.3.3.3.1 Australia and New Zealand Radiation Dose Management (by End User)
      • 14.3.3.4 South Korea
        • 14.3.3.4.1 South Korea Radiation Dose Management (by End User)
      • 14.3.3.5 India
        • 14.3.3.5.1 India Radiation Dose Management (by End User)
      • 14.3.3.6 Rest-of-Asia-Pacific
        • 14.3.3.6.1 Rest of Asia-Pacific Radiation Dose Management (by End User)
    • 14.3.4 Regulations
    • 14.3.5 Developments
  • 14.4 Latin America
    • 14.4.1 Latin America Radiation Dose Management Market (by Modality)
    • 14.4.2 Latin America Radiation Dose Management (by End User)
    • 14.4.3 Latin America Radiation Dose Management Market (by Country)
      • 14.4.3.1 Brazil
      • 14.4.3.2 Brazil Radiation Dose Management (by End User)
      • 14.4.3.3 Mexico
        • 14.4.3.3.1 Mexico Radiation Dose Management (by End User)
      • 14.4.3.4 Rest-of-Latin America
        • 14.4.3.4.1 Rest-of-Latin America Radiation Dose Management (by End User)
    • 14.4.4 Regulations
  • 14.5 Rest-of-the-World
    • 14.5.1 Rest-of-the-World Radiation Dose Management Market (by Modality)
    • 14.5.2 Rest-of-the-World Radiation Dose Management (by End User)
    • 14.5.3 Rest-of-the-World Radiation Dose Management Market (by Country)
      • 14.5.3.1 Middle East
        • 14.5.3.1.1 Middle East Radiation Dose Management (by End User)
      • 14.5.3.2 Africa
        • 14.5.3.2.1 Africa Radiation Dose Management (by End User)
    • 14.5.4 Regulations

15 Company Profiles

  • 15.1 Agfa-Gevaert Group
    • 15.1.1 Company Overview
    • 15.1.2 Role of Agfa Gevaert Group in the Radiation Dose Management Market
    • 15.1.3 Financials
    • 15.1.4 Recent Development
    • 15.1.5 SWOT Analysis
  • 15.2 Bayer AG
    • 15.2.1 Company Overview
    • 15.2.2 Role of Bayer AG in the Radiation Dose Management Market
    • 15.2.3 Financials
    • 15.2.4 Recent Development
    • 15.2.5 SWOT Analysis
  • 15.3 Bracco
    • 15.3.1 Company Overview
    • 15.3.2 Role of Bracco in the Radiation Dose Management Market
    • 15.3.3 Recent Development
    • 15.3.4 SWOT Analysis
  • 15.4 Canon Inc.
    • 15.4.1 Company Overview
    • 15.4.2 Role of Canon Inc. in the Radiation Dose Management Market
    • 15.4.3 Financials
    • 15.4.4 Recent Development
    • 15.4.5 SWOT Analysis
  • 15.5 Fujifilm Holdings Corporation
    • 15.5.1 Company Overview
    • 15.5.2 Role of Fujifilm Holdings Corporation in the Radiation Dose Management Market
    • 15.5.3 Financials
    • 15.5.4 SWOT Analysis
  • 15.6 Guerbet Group
    • 15.6.1 Company Overview
    • 15.6.2 Role of Guerbet LLC in the Radiation Dose Management Market
    • 15.6.3 Financials
    • 15.6.4 Recent Development
    • 15.6.5 SWOT Analysis
  • 15.7 General Electric Company
    • 15.7.1 Company Overview
    • 15.7.2 Role of General Electric Company in Radiation Dose Management Market
    • 15.7.3 Financials
    • 15.7.4 Recent Development
    • 15.7.5 SWOT Analysis
  • 15.8 Imalogix
    • 15.8.1 Company Overview
    • 15.8.2 Role of Imalogix in the Radiation Dose Management Market
    • 15.8.3 Recent Development
    • 15.8.4 SWOT Analysis
  • 15.9 Infinitt Healthcare Co., Ltd.
    • 15.9.1 Company Overview
    • 15.9.2 Role of Infinitt Healthcare Co., Ltd. in the Radiation Dose Management Market
    • 15.9.3 Recent Development
    • 15.9.4 SWOT Analysis
  • 15.1 Koninklijke Philips N.V.
    • 15.10.1 Company Overview
    • 15.10.2 Role of Koninklijke Philips N.V. in the Radiation Dose Management Market
    • 15.10.3 Financials
    • 15.10.4 Recent Development
    • 15.10.5 SWOT Analysis
  • 15.11 Medic Vision Imaging Solutions Ltd.
    • 15.11.1 Company Overview
    • 15.11.2 Role of Medic Vision Imaging Solutions Ltd. in the Radiation Dose Management Market
    • 15.11.3 Recent Development
    • 15.11.4 SWOT Analysis
  • 15.12 Medsquare
    • 15.12.1 Company Overview
    • 15.12.2 Role of Medsquare in the Radiation Dose Management Market
    • 15.12.3 Recent Development
    • 15.12.4 SWOT Analysis
  • 15.13 MyXrayDose Ltd.
    • 15.13.1 Company Overview
    • 15.13.2 Role of MyXrayDose Ltd. in the Radiation Dose Management Market
    • 15.13.3 SWOT Analysis
  • 15.14 Novarad Corporation
    • 15.14.1 Company Overview
    • 15.14.2 Role of Novarad Corporation in the Radiation Dose Management Market
    • 15.14.3 Recent Development
    • 15.14.4 SWOT Analysis
  • 15.15 PACSHealth, LLC
    • 15.15.1 Company Overview
    • 15.15.2 Role of PACSHealth LLC in the Radiation Dose Management Market
    • 15.15.3 Recent Development
    • 15.15.4 SWOT Analysis
  • 15.16 Qaelum NV
    • 15.16.1 Company Overview
    • 15.16.2 Role of Qaelum NV in the Radiation Dose Management Market
    • 15.16.3 Recent Development
    • 15.16.4 SWOT Analysis
  • 15.17 Sectra AB
    • 15.17.1 Company Overview
    • 15.17.2 Role of Sectra AB in the Radiation Dose Management Market
    • 15.17.3 Financials
    • 15.17.4 Recent Development
    • 15.17.5 SWOT Analysis
  • 15.18 SST Group Inc.
    • 15.18.1 Company Overview
    • 15.18.2 Role of SST Group Inc. in the Radiation Dose Management Market
    • 15.18.3 Recent Development
    • 15.18.4 SWOT Analysis
  • 15.19 Siemens Healthineers, Inc.
    • 15.19.1 Company Overview
    • 15.19.2 Role of Siemens Healthineers, Inc. in the Radiation Dose Management Market
    • 15.19.3 Financials
    • 15.19.4 Recent Development
    • 15.19.5 SWOT Analysis
  • 15.2 Virtual Phantom, Inc.
    • 15.20.1 Company Overview
    • 15.20.2 Role of Virtual Phantom, Inc. in the Radiation Dose Management Market
    • 15.20.3 Key Developments
    • 15.20.4 SWOT Analysis